![Yuichi Iwaki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yuichi Iwaki
Directeur Général chez
MEDICINOVA, INC.
Fortune : 1 M $ au 30/06/2026
Profil
Yuichi Iwaki is the founder of MediciNova, Inc., founded in 2000, serving as Chairman, President & Chief Executive Officer.
Current jobs include Director-Transplantation Immunology at the University of South Carolina School of Medicine since 1992 and Professor at the University of Southern California.
Former jobs include Chairman & Acting Chief Executive Officer at AMCOL International Corp., Director at Antyra, Inc., Director at Avigen, Inc. from 1994 to 2008, and Professor at the University of Pittsburgh School of Medicine from 1989 to 1991.
Education includes a doctorate from Sapporo Medical University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MEDICINOVA, INC. 2,22 % | 24/04/2026 | 1 091 933 ( 2,22 % ) | 1 M $ | 30/06/2026 |
Postes actifs de Yuichi Iwaki
| Sociétés | Poste | Début |
|---|---|---|
| MEDICINOVA, INC. | Directeur Général | 01/08/2005 |
University of South Carolina School of Medicine
 University of South Carolina School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1992 |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Yuichi Iwaki
| Sociétés | Poste | Fin |
|---|---|---|
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Develops gene therapy products | Directeur/Membre du Conseil | 01/01/2008 |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1991 |
Antyra, Inc.
 Antyra, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Directeur/Membre du Conseil | - |
| AMCOL INTERNATIONAL CORPORATION | Président | - |
Formation de Yuichi Iwaki
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
AMCOL International Corp.
 AMCOL International Corp. Other Metals/MineralsNon-Energy Minerals Produces and markets specialty minerals & chemicals | Non-Energy Minerals |
Avigen, Inc.
Avigen, Inc. Medical SpecialtiesHealth Technology Develops gene therapy products | Health Technology |
MediciNova, Inc.
 MediciNova, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which develops novel therapeutics for the treatment of neurological and other disorders | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antyra, Inc.
Antyra, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Sapporo Medical University School of Medicine
 Sapporo Medical University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Carolina School of Medicine
University of South Carolina School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
